Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today.
This finding raises potential concerns about quality of care, and the researchers say it may be appropriate to re-examine the current status of personal payments from the drug industry to physicians.
The two non-recommended drugs were denosumab, a bone modifying drug for castration sensitive prostate cancer, and granulocyte colony stimulating factors to prevent neutropenic fever in patients receiving chemotherapy. The results show that the proportion of patients who received non-recommended denosumab within six months of their diagnosis was 31.4% for those whose oncologist had not received payment and 49.5% for those whose oncologist had.
Smaller effects were seen after further adjusting for physicians' characteristics including specialist area and practice setting. For example, payments from industry were associated with a 7.4% greater use of denosumab and a 1.7% greater use of nabpaclitaxel, but not with GCSF or branded drugs.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
After body contouring, bariatric surgery patients regain more weight than non-bariatric patients: StudyPatients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to BC patients who did not have bariatric surgery, reports a study in Plastic and Reconstructive Surgery.
Read more »
COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study findsA recent study in the 'Journal of Clinical Medicine' explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS).
Read more »
Study shows benefit of convalescent plasma in Covid-19 patients requiring artificial ventilationIn a study published in The New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection with Sars-CoV-2 to patients suffering from acute respiratory distress syndrome requiring artificial mechanical ventilation...
Read more »
New study reveals inequities in access to mechanical circulatory support in US patients with cardiogenic shockA new study presented today at the Transcatheter Cardiovascular Therapeutics (TCT) conference 2023 sought to evaluate the presence of racial, ethnic, and socioeconomic inequities in access to mechanical circulatory support in the United States among patients with cardiogenic shock (CS).
Read more »
Industry payments to physicians linked to use of some non-recommended and low-value drugs among cancer patientsPatients with cancer whose oncologists receive payments from industry appear more likely to receive some non-recommended and low-value treatments, finds a US study published by The BMJ today.
Read more »
NHS patients still face postcode lottery for urgent care, damning MPs' report findsPeople in some parts of the country are having to wait, on average, more than three minutes longer for an ambulance to arrive when they are facing a life-threatening emergency, the Public Accounts Committee finds.
Read more »